MBX Biosciences Files 2025 Annual Report
Ticker: MBX · Form: ARS · Filed: Apr 22, 2026 · CIK: 0001776111
Sentiment: neutral
Topics: annual-report, financials, sec-filing
TL;DR
MBX Biosciences filed its 2025 ARS on 4/22/26. Check financials.
AI Summary
MBX Biosciences, Inc. filed its Annual Report to Security Holders (ARS) on April 22, 2026, for the period ending December 31, 2025. The filing includes the complete submission text file and a PDF document detailing the company's year-end financial information. MBX Biosciences, Inc. is located in Carmel, Indiana, and operates within the Pharmaceutical Preparations sector.
Why It Matters
This filing provides shareholders and potential investors with a comprehensive overview of MBX Biosciences, Inc.'s financial performance and operational status for the fiscal year 2025.
Risk Assessment
Risk Level: low — This is a routine annual report filing and does not contain information indicating significant new risks.
Key Players & Entities
- MBX Biosciences, Inc. (company) — Filer of the ARS
- 0001776111 (company) — CIK number for MBX Biosciences, Inc.
- 2026-04-22 (date) — Filing Date and Effectiveness Date
- 2025-12-31 (date) — Period of Report
- 11711 N. MERIDIAN STREET SUITE 300 CARMEL IN 46032 (address) — Mailing and Business Address
FAQ
What type of filing is this?
This is an Annual Report to Security Holders (ARS) filing.
When was this filing accepted by the SEC?
The filing was accepted on April 22, 2026.
What period does this report cover?
The period of the report is for the year ending December 31, 2025.
What is the CIK number for MBX Biosciences, Inc.?
The CIK number for MBX Biosciences, Inc. is 0001776111.
What is the primary business sector for MBX Biosciences, Inc.?
MBX Biosciences, Inc. operates in the Pharmaceutical Preparations sector (SIC 2834).
Filing Details
This Form ARS (Form ARS) was filed with the SEC on April 22, 2026 regarding MBX Biosciences, Inc. (MBX).